Literature DB >> 22147028

The use of polymerase chain reaction to confirm diagnosis in skin biopsies consistent with American tegumentary leishmaniasis at histopathology: a study of 90 cases.

Rosilene Viana de Andrade1, Cesare Massone, Meline Nogueira Barbosa de Lucena, Anette Chusciak Talhari, Sinésio Talhari, Jorge Augusto de Oliveira Guerra, Luiz Carlos de Lima Ferreira.   

Abstract

BACKGROUND: Cutaneous leishmaniasis is a chronic, infectious disease caused by protozoa of the genus leishmania. The incidence of this disease is high in Brazil, with 19,746 new cases having been detected in 2008. The presence of amastigotes in the cytoplasm of histiocytes constitutes diagnosis of the disease; however, their presence is rarely found in late lesions, making histological diagnosis difficult. Polymerase chain reaction has been shown to represent a highly sensitive and specific technique for the diagnosis of cutaneous leishmaniasis.
OBJECTIVES: To use polymerase chain reaction to evaluate paraffin-embedded skin biopsies with histopathological features consistent with cutaneous leishmaniasis.
MATERIAL AND METHODS: Polymerase chain reaction amplification of a 120-base-pair fragment of Leishmania kinetoplast DNA (kDNA) minicircles was performed on 90 skin biopsies. The male/female ratio was 75/15. Mean age was 32.36 years, with a median of 31 years, range 4-72 years. Samples were histologically compatible with cutaneous leishmaniasis but a definitive diagnosis could not be made since amastigotes were not found. All cases were histologically classified according to the patterns described by de Magalhães.
RESULTS: According to the de Magalhães classification, the most common histological pattern was type IV (exudative granulomatous reaction), which was found in 65.6% of cases (56/90), followed by type I (exudative cellular reaction) in 21.1% of cases (19/90) and type III (exudative and necrotic granulomatous reaction) in 12.2% of cases (11/90). Leishmania DNA was found in 96.7% of the biopsies (87/90).
CONCLUSION: Polymerase chain reaction performed by amplifying kDNA is able to confirm a diagnosis of cutaneous leishmaniasis with a high degree of sensitivity in cases in which histopathology is consistent with a diagnosis of cutaneous leishmaniasis but not definitive.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22147028     DOI: 10.1590/s0365-05962011000500005

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  6 in total

1.  American cutaneous leishmaniasis: epidemiological profile of patients treated in Londrina from 1998 to 2009.

Authors:  Rubens Pontello Junior; Airton dos Santos Gon; Alessandra Ogama
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study.

Authors:  Mirella A Cunha; Aline C Q Leão; Rita de Cassia Soler; José Angelo L Lindoso
Journal:  Am J Trop Med Hyg       Date:  2015-10-19       Impact factor: 2.345

3.  Case Report: Mucosal Leishmaniasis Presenting with Nasal Septum Perforation after Almost Thirty Years.

Authors:  Jesùs Rojas-Jaimes; Helena L Frischtak; Jose Arenas; Andres G Lescano
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

Review 4.  Detection of microorganisms in granulomas that have been formalin-fixed: review of the literature regarding use of molecular methods.

Authors:  Jeannette Guarner
Journal:  Scientifica (Cairo)       Date:  2012-12-31

5.  Applicability of kDNA-PCR for routine diagnosis of American tegumentary leishmaniasis in a tertiary reference hospital.

Authors:  Marcela M Satow; Edite H Yamashiro-Kanashiro; Mussya C Rocha; Luiza K Oyafuso; Rita C Soler; Paulo C Cotrim; José Angelo L Lindoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Nov-Dec       Impact factor: 1.846

6.  Identification of Leishmania species by high-resolution DNA dissociation in cases of American cutaneous leishmaniasis.

Authors:  John Verrinder Veasey; Ricardo Andrade Zampieri; Rute Facchini Lellis; Thaís Helena Proença de Freitas; Lucile Maria Floeter Winter
Journal:  An Bras Dermatol       Date:  2020-05-15       Impact factor: 1.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.